Inventor · disambiguated record
Leonie Alten
Also filed as: ALTEN LEONIE
27 granted patents·9 pending applications·259 citations·filing 2017–2025
97Inventor score
Files withIMMATICS BIOTECHNOLOGIES GMBH36
Top patents by PatentIndex Score
36 records- 0198US11111294B2T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Sep 7, 2021·11 cites·15 claims
- 0298US10723796B2T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Jul 28, 2020·22 cites·20 claims
- 0398US10590194B2T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Mar 17, 2020·23 cites·17 claims
- 0497US10889629B2Transfected T-cells and T-cell receptors for use in immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jan 12, 2021·4 cites·20 claims
- 0597US10800832B2T cell receptors and immune therapy using the same against prame positive cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Oct 13, 2020·19 cites·14 claims
- 0697US10800845B2T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Oct 13, 2020·12 cites·19 claims
- 0797US10725044B2T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Jul 28, 2020·12 cites·30 claims
- 0897US10702609B2T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Jul 7, 2020·14 cites·33 claims
- 0997US10626160B2Transfected T-cells and T-cell receptors for use in immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Apr 21, 2020·14 cites·20 claims
- 1097US10596242B2Transfected T-cells and T-cell receptors for use in immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Mar 24, 2020·12 cites·20 claims
- 1197US10550182B2T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted Feb 4, 2020·15 cites·8 claims
- 1297US10526407B2T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Jan 7, 2020·17 cites·24 claims
- 1397US10527623B2T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted Jan 7, 2020·13 cites·9 claims
- 1496US10618956B2Engineered T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Apr 14, 2020·13 cites·16 claims
- 1595US11072645B2T cell receptors with improved pairingIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted Jul 27, 2021·10 cites·5 claims
- 1695US10538573B2Transfected T-cells and T-cell receptors for use in immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted Jan 21, 2020·20 cites·21 claims
- 1794US10889645B2Engineered T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jan 12, 2021·3 cites·20 claims
- 1893US10537624B2Transfected T-cells and T-cell receptors for use in immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted Jan 21, 2020·15 cites·13 claims
- 1991US10874731B2T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted Dec 29, 2020·4 cites·15 claims
- 2090US2025154246A1Novel t cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2024·Application pending·0 cites
- 2189US11236145B2T cell receptors and immune therapy using the same against PRAME positive cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Feb 1, 2022·3 cites·25 claims
- 2289US11111286B2T cell receptors and immune therapy using the same against PRAME positive cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Sep 7, 2021·3 cites·20 claims
- 2384US2024279308A1Transfected t-cells and t-cell receptors for use in immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2024·Application pending·0 cites
- 2484US2024228611A1Novel engineered t cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2024·Application pending·0 cites
- 2582US2023321208A1Transfected t-cells and t-cell receptors for use in immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2023·Application pending·0 cites
- 2681US2024285779A1Novel t cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2024·Application pending·0 cites
- 2776US2021388079A1Novel t cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Application pending·0 cites
- 2875US11945854B2Transfected T-cells and T-cell receptors for use in immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Apr 2, 2024·0 cites·20 claims
- 2975US11932689B2Engineered T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Mar 19, 2024·0 cites·20 claims
- 3073US11730796B2Transfected t-cells and t-cell receptors for use in immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Aug 22, 2023·0 cites·24 claims
- 3172US12297252B2T cell receptors with improved pairingIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted May 13, 2025·0 cites·10 claims
- 3269US11998607B2T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jun 4, 2024·0 cites·25 claims
- 3368US11939376B2T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Mar 26, 2024·0 cites·20 claims
- 3468US2020249233A1Novel t cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Application pending·0 cites
- 3566US2022098270A1T cell receptors and immune therapy using the same against prame positive cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Application pending·0 cites
- 3647US2025163124A1T cell receptors with improved pairingIMMATICS BIOTECHNOLOGIES GMBH·Filed 2025·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →